TPST Company Profile and Key Details

Q: Who are the executives of TPST?

Dr. Sharon Sakai Ph.D., RACHead of Regulatory & QualityMr. Stephen R. Brady J.D., LLMChief Executive Officer & DirectorDr. Thomas W. Dubensky Jr., Ph.D.Pres & DirectorDr. Samuel Whiting M.D., Ph.D.Executive Vice President & Chief Medical OfficerMr. Petpiboon PrasitActing Chief Scientific Officer & Executive DirectorMr. Justin TrojanowskiCorporation Controller, Treasurer & Principal Accounting OfficerDr. Anne MoonSenior Vice President and Head of Project Team Leadership, Project Management & Portfolio ManagementMr. Nicholas MaestasVice President of Strategy & Fin. and Sec.

NASDAQ : TPST

Tempest Therapeutics

$0.86

-0.0074-0.86%

At Close 4:00 PM

56.08

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Tempest Therapeutics, Inc. (TPST) stock declined over -0.86%, trading at $0.86 on NASDAQ, down from the previous close of $0.86. The stock opened at $0.88, fluctuating between $0.85 and $0.89 in the recent session.

Stock Snapshot

0.8637

Prev. Close

3.8M

Market Cap

0.8526

Day Low

-0.14

P/E Ratio

-6.01

EPS (TTM)

-1.28

Cash Flow per Share

0.88

Open

4.44M

Number of Shares

0.8878

Day High

87.55%

Free Float in %

1.24

Book Value

68.93K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 31, 2026	0.88	0.89	0.85	0.86	69.03K
Jul 30, 2026	0.89	0.90	0.86	0.86	40.39K
Jul 29, 2026	0.85	0.92	0.84	0.89	155.7K
Jul 28, 2026	0.94	0.96	0.87	0.87	147.53K
Jul 27, 2026	0.91	0.98	0.91	0.93	127.35K
Jul 24, 2026	0.93	0.99	0.87	0.93	251.91K
Jul 23, 2026	0.97	1.00	0.93	0.94	464.71K
Jul 22, 2026	0.98	0.99	0.95	0.95	83.6K
Jul 21, 2026	0.95	1.03	0.94	0.99	492.97K
Jul 20, 2026	0.97	0.98	0.94	0.95	95.53K
Jul 17, 2026	0.99	1.00	0.93	0.97	206.29K
Jul 16, 2026	1.05	1.05	0.96	0.98	120.45K
Jul 15, 2026	1.00	1.09	0.98	1.07	267.46K
Jul 14, 2026	0.98	1.04	0.94	0.98	171.89K
Jul 13, 2026	1.00	1.08	0.97	0.98	433.91K
Jul 10, 2026	0.98	1.00	0.96	0.97	94.07K
Jul 09, 2026	0.99	1.01	0.96	0.97	60.27K
Jul 08, 2026	0.98	1.02	0.95	0.99	163.64K
Jul 07, 2026	1.07	1.08	0.95	0.99	141.26K
Jul 06, 2026	1.07	1.10	1.04	1.07	99.6K

Contact Details

Brisbane, CA 94080

United States

https://www.tempesttx.com 415 798 8589

About Company

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for its role in regulating the innate immune response within cancerous growths. Established in 2011, Tempest Therapeutics Inc. is headquartered in South San Francisco, California, having previously operated as a subsidiary of Inception Sciences, Inc.

Stock Peers

ARGX

-18.76-2.15%

argenx SE$853.82 REGN

24.29+3.29%

Regeneron Pharmaceuticals, Inc.$762.63 UTHR

-8.11-1.54%

United Therapeutics Corporation$517.71 VRTX

-4.6-0.95%

Vertex Pharmaceuticals Incorporated$477.10 MDGL

-25.79-5.23%

Madrigal Pharmaceuticals, Inc.$467.32 KRYS

-25.73-7.01%

Krystal Biotech, Inc.$341.12 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

-6.07-1.88%

BeOne Medicines AG$316.01 PRAX

0.08+0.03%

Praxis Precision Medicines, Inc.$307.83 LGND

-8.75-2.95%

Ligand Pharmaceuticals Incorporated$287.54

Frequently Asked Questions

What is the current Tempest Therapeutics, Inc. (TPST) stock price?

Tempest Therapeutics, Inc. (NASDAQ: TPST) stock price is $0.86 in the last trading session. During the trading session, TPST stock reached the peak price of $0.89 while $0.85 was the lowest point it dropped to. The percentage change in TPST stock occurred in the recent session was -0.86% while the dollar amount for the price change in TPST stock was - $0.01.

TPST's industry and sector of operation?

The NASDAQ listed TPST is part of Biotechnology industry that operates in the broader Healthcare sector. Tempest Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TPST?

Dr. Sharon Sakai Ph.D., RAC
Head of Regulatory & Quality
Mr. Stephen R. Brady J.D., LLM
Chief Executive Officer & Director
Dr. Thomas W. Dubensky Jr., Ph.D.
Pres & Director
Dr. Samuel Whiting M.D., Ph.D.
Executive Vice President & Chief Medical Officer
Mr. Petpiboon Prasit
Acting Chief Scientific Officer & Executive Director
Mr. Justin Trojanowski
Corporation Controller, Treasurer & Principal Accounting Officer
Dr. Anne Moon
Senior Vice President and Head of Project Team Leadership, Project Management & Portfolio Management
Mr. Nicholas Maestas
Vice President of Strategy & Fin. and Sec.

How TPST did perform over past 52-week?

TPST's closing price is 1.94% higher than its 52-week low of $0.84 where as its distance from 52-week high of $12.23 is -93%.

How many employees does TPST have?

Number of TPST employees currently stands at 4.

Link for TPST official website?

Official Website of TPST is: https://www.tempesttx.com

How do I contact TPST?

TPST could be contacted at phone 415 798 8589 and can also be accessed through its website. TPST operates from 2000 Sierra Point Parkway, Brisbane, CA 94080, United States.

How many shares of TPST are traded daily?

TPST stock volume for the day was 68.93K shares. The average number of TPST shares traded daily for last 3 months was 156.95K.

What is the market cap of TPST currently?

The market value of TPST currently stands at $3.80M with its latest stock price at $0.86 and 4.44M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	4
Beta	-1.71
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	4
Beta	-1.71
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

TPST Company Profile and Key Details

Tempest Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook